These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36938730)

  • 1. Construction and validation of a prognostic model based on ten signature cell cycle-related genes for early-stage lung squamous cell carcinoma.
    Zhang C; Huang Y; Fang C; Liang Y; Jiang D; Li J; Ma H; Jiang W; Feng Y
    Cancer Biomark; 2023; 36(4):313-326. PubMed ID: 36938730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
    Xu HH; Wang HL; Xing TJ; Wang XQ
    Front Immunol; 2022; 13():851622. PubMed ID: 35924232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Signature for Lung Adenocarcinoma Patients Based on Cell-Cycle-Related Genes.
    Jiang W; Xu J; Liao Z; Li G; Zhang C; Feng Y
    Front Cell Dev Biol; 2021; 9():655950. PubMed ID: 33869220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and validation of a metabolic-related genes prognostic model for oral squamous cell carcinoma based on bioinformatics.
    Zhang J; Ma C; Qin H; Wang Z; Zhu C; Liu X; Hao X; Liu J; Li L; Cai Z
    BMC Med Genomics; 2022 Dec; 15(1):269. PubMed ID: 36566175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients.
    Yan D; Chen Y
    Sci Rep; 2021 Apr; 11(1):9020. PubMed ID: 33907270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients.
    Wang K; Li Y; Wang J; Chen R; Li J
    Clin Transl Oncol; 2021 Nov; 23(11):2368-2381. PubMed ID: 34028782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of pyroptosis-related long non-coding RNAs with prognosis and therapy in lung squamous cell carcinoma.
    Zhang Y; Wang Y; Yin X; Huang Y
    Sci Rep; 2022 Jul; 12(1):11206. PubMed ID: 35778526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification and prognosis prediction based on inflammation-related gene signature in lung squamous carcinoma.
    Zhai W; Chen S; Duan F; Wang J; Zhao Z; Lin Y; Rao B; Wang Y; Zheng L; Long H
    Cancer Med; 2023 Feb; 12(4):4968-4980. PubMed ID: 36056909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a prognostic model for lung squamous cell carcinoma based on immune-related genes.
    Pu J; Teng Z; Yang W; Zhu P; Zhang T; Zhang D; Wang B; Hu Z; Song Q
    Carcinogenesis; 2023 May; 44(2):143-152. PubMed ID: 36455238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma.
    Zhang Z; Lin E; Zhuang H; Xie L; Feng X; Liu J; Yu Y
    Cancer Cell Int; 2020; 20():27. PubMed ID: 32002016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel signature derived from metabolism-related genes GPT and SMS to predict prognosis of laryngeal squamous cell carcinoma.
    Shen Y; Huang Q; Zhang Y; Hsueh CY; Zhou L
    Cancer Cell Int; 2022 Jul; 22(1):226. PubMed ID: 35804447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients.
    Li H; Zhang X; Yi C; He Y; Chen X; Zhao W; Yu D
    BMC Cancer; 2021 Jul; 21(1):835. PubMed ID: 34284753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
    Yue C; Ma H; Zhou Y
    PeerJ; 2019; 7():e8128. PubMed ID: 31803536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 5 Gene Signatures in Survival Prediction for Patients with Lung Squamous Cell Carcinoma Based on Integrated Multiomics Data Analysis.
    Ma H; Tong L; Zhang Q; Chang W; Li F
    Biomed Res Int; 2020; 2020():6427483. PubMed ID: 32596344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of methylation-driven genes prognostic signature for recurrence of laryngeal squamous cell carcinoma by integrated bioinformatics analysis.
    Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G
    Cancer Cell Int; 2020; 20():472. PubMed ID: 33005105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A ferroptosis-related gene signature for overall survival prediction and immune infiltration in lung squamous cell carcinoma.
    Miao TW; Yang DQ; Chen FY; Zhu Q; Chen X
    Biosci Rep; 2022 Aug; 42(8):. PubMed ID: 35866375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival-associated N
    Qu J; Wang L; Jiang M; Wei Z; Fu G; Zhang X
    BMC Cancer; 2021 Nov; 21(1):1265. PubMed ID: 34814861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.